http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35177034

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, U.S. Gov't, Non-P.H.S.|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 711
issn 1552-4450
1552-4469
issueIdentifier 6
pageRange 703-711
publicationName Nature Chemical Biology
startingPage 703
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d93afe28c9110e0c1480cb2c276ab22d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fca73b6cef5d3df56e19b2d238cde805
bibliographicCitation Kaneshige A, Bai L, Wang M, McEachern D, Meagher JL, Xu R, Wang Y, Jiang W, Metwally H, Kirchhoff PD, Zhao L, Jiang H, Wang M, Wen B, Sun D, Stuckey JA, Wang S. A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo. Nat Chem Biol. 2023 Jun;19(6):703–11. doi: 10.1038/s41589-022-01248-4. PMID: 36732620.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68df2ab91076db768ffb883403854604
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6406-2126
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c9fcbe100673b806eb1bac32947e1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d5f61fae43657fb9ca4141d4b7d8467
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13324309f1c0ca155f800b6d080123b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2523d3dace15ce09b8704115ecf13287
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a24dc01ebdd57c58d48d1547f2652d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07de058526a3ac9dcd2e5708bf192ae4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f66cf6857b1771de1523c3c1240efa08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ca780265457672aa2a7ac97b2ede5e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5956-3009
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4192-8900
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4509-9561
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8337-220X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2718-9811
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e2d3ef0598d1ae2fcf3d5f9fbd514a8
date 2023-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/s41589-022-01248-4
https://pubmed.ncbi.nlm.nih.gov/36732620
isPartOf https://portal.issn.org/resource/ISSN/1552-4469
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32624
https://portal.issn.org/resource/ISSN/1552-4450
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
discusses http://id.nlm.nih.gov/mesh/M0420149
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ec8514d1555b5925e183b8667575854c
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a5b54f0f79fca3f7edae711252821b60

Total number of triples: 44.